These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

966 related items for PubMed ID: 3027302

  • 1. Continuous intrathecal opioid analgesia: tolerance and cross-tolerance of mu and delta spinal opioid receptors.
    Russell RD, Leslie JB, Su YF, Watkins WD, Chang KJ.
    J Pharmacol Exp Ther; 1987 Jan; 240(1):150-8. PubMed ID: 3027302
    [Abstract] [Full Text] [Related]

  • 2. Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [D-Pen2, D-Pen5]enkephalin in the mouse.
    Porreca F, Heyman JS, Mosberg HI, Omnaas JR, Vaught JL.
    J Pharmacol Exp Ther; 1987 May; 241(2):393-400. PubMed ID: 3033214
    [Abstract] [Full Text] [Related]

  • 3. Role of peripheral mu, delta and kappa opioid receptors in opioid-induced inhibition of gastrointestinal transit in rats.
    Tavani A, Petrillo P, La Regina A, Sbacchi M.
    J Pharmacol Exp Ther; 1990 Jul; 254(1):91-7. PubMed ID: 2164103
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Action at the mu receptor is sufficient to explain the supraspinal analgesic effect of opiates.
    Fang FG, Fields HL, Lee NM.
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1039-44. PubMed ID: 3018217
    [Abstract] [Full Text] [Related]

  • 7. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
    Porreca F, Mosberg HI, Hurst R, Hruby VJ, Burks TF.
    J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883
    [Abstract] [Full Text] [Related]

  • 8. Mu opioid antagonist properties of a cyclic somatostatin octapeptide in vivo: identification of mu receptor-related functions.
    Shook JE, Pelton JT, Lemcke PK, Porreca F, Hruby VJ, Burks TF.
    J Pharmacol Exp Ther; 1987 Jul; 242(1):1-7. PubMed ID: 2886635
    [Abstract] [Full Text] [Related]

  • 9. The role of mu- and delta- opioid receptors on the intestinal propulsion in rats.
    Sbacchi M, La Regina A, Petrillo P, Tavani A.
    NIDA Res Monogr; 1986 Jul; 75():520-3. PubMed ID: 2828999
    [Abstract] [Full Text] [Related]

  • 10. Differential modulation by [D-Pen2, D-Pen5]enkephalin and dynorphin A-(1-17) of the inhibitory bladder motility effects of selected mu agonists in vivo.
    Sheldon RJ, Nunan L, Porreca F.
    J Pharmacol Exp Ther; 1989 May; 249(2):462-9. PubMed ID: 2566676
    [Abstract] [Full Text] [Related]

  • 11. Behavioral effects of opioid peptides selective for mu or delta receptors. I. Morphine-like discriminative stimulus effects.
    Locke KW, Holtzman SG.
    J Pharmacol Exp Ther; 1986 Sep; 238(3):990-6. PubMed ID: 3018230
    [Abstract] [Full Text] [Related]

  • 12. Peptide opioid antagonist separates peripheral and central opioid antitransit effects.
    Shook JE, Pelton JT, Hruby VJ, Burks TF.
    J Pharmacol Exp Ther; 1987 Nov; 243(2):492-500. PubMed ID: 2824748
    [Abstract] [Full Text] [Related]

  • 13. Behavioral effects of opioid peptides selective for mu or delta receptors. II. Locomotor activity in nondependent and morphine-dependent rats.
    Locke KW, Holtzman SG.
    J Pharmacol Exp Ther; 1986 Sep; 238(3):997-1003. PubMed ID: 3018231
    [Abstract] [Full Text] [Related]

  • 14. Continuous intrathecal opioid treatment abolishes the regulatory effects of magnesium and guanine nucleotides on mu opioid receptor binding in rat spinal membranes.
    Wong CS, Su YF, Watkins WD, Chang KJ.
    J Pharmacol Exp Ther; 1992 Jul; 262(1):317-26. PubMed ID: 1320689
    [Abstract] [Full Text] [Related]

  • 15. Spinal interactions between opioid and noradrenergic agonists in mice: multiplicativity involves delta and alpha-2 receptors.
    Roerig SC, Lei S, Kitto K, Hylden JK, Wilcox GL.
    J Pharmacol Exp Ther; 1992 Jul; 262(1):365-74. PubMed ID: 1378095
    [Abstract] [Full Text] [Related]

  • 16. Sympathoadrenal, cardiovascular and blood gas responses to highly selective mu and delta opioid peptides.
    Kiritsy-Roy JA, Marson L, Van Loon GR.
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1096-103. PubMed ID: 2557411
    [Abstract] [Full Text] [Related]

  • 17. Spinal opioid receptors and adenosine release: neurochemical and behavioral characterization of opioid subtypes.
    Cahill CM, White TD, Sawynok J.
    J Pharmacol Exp Ther; 1995 Oct; 275(1):84-93. PubMed ID: 7562600
    [Abstract] [Full Text] [Related]

  • 18. Dissociation of mu opioid tolerance from receptor down-regulation in rat spinal cord.
    Nishino K, Su YF, Wong CS, Watkins WD, Chang KJ.
    J Pharmacol Exp Ther; 1990 Apr; 253(1):67-72. PubMed ID: 2158554
    [Abstract] [Full Text] [Related]

  • 19. Tolerance and cross-tolerance to the antisecretory effects of enkephalins on the guinea-pig ileal mucosa.
    Vinayek R, Brown DR, Miller RJ.
    J Pharmacol Exp Ther; 1985 Mar; 232(3):781-5. PubMed ID: 2983070
    [Abstract] [Full Text] [Related]

  • 20. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
    He L, Lee NM.
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.